The University of Texas MD Anderson Cancer Centre - Articles and news items

PharmaMar initiates a phase III ATLANTIS study in patients with small cell lung cancer

BMS and MD Anderson in lung cancer research collaboration

Industry news / 7 June 2016 / Victoria White, Digital Content Producer

BMS and MD Anderson are to collaborate to evaluate innovative strategies for the use of Opdivo and Yervoy to treat lung cancer patients…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...